Thirty Madison is a full-service healthcare company in New York that focuses on providing medications. Founded 2017 in New York, United States by Demetri Karagas and Steven Gutentag, Thirty Madison has raised a total of $22.8M in funding over two rounds. Their latest funding was raised on October 16, 2018 from a Series A round. Thirty Madison is funded by 8 investors. As of March 2020, Steadfast Venture Capital and Greycroft are the most recent investors. Thirty Madison combines virtual diagnosis and FDA-approved treatments to create access to preventative medicine and care for men experiencing hair loss.
Timeline
August 17, 2020
Thirty Madison raises $47 million in a series B funding round led by healthcare venture capital firm Polaris Partners. Johnson & Johnson's innovation arm, Johnson & Johnson Innovation – JJDC, Inc., joined the round as a new investor. Existing investors Maveron and Northzone also participated in that round.
2017
Founded
Funding rounds
Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
People
Name
Role
LinkedIn
Demetri Karagas
Founder
Steven Gutentag
Founder
Further reading
Title
Author
Link
Type
Date
Documentaries, videos and podcasts
Title
Date
Link
Companies
Company
CEO
Location
Products/Services
News
Title
Author
Date
Publisher
Description
AlleyWatch
December 1, 2020
AlleyWatch
The Pulse of New York Tech
Heather Landi
August 17, 2020
FierceHealthcare
Johnson & Johnson is investing in direct-to-consumer telehealth company Thirty Madison. The New York City-based startup offers telehealth visits and online prescriptions for drugs for hair loss, migraines and acid reflux. Here's why the pharmaceutical giant is backing the telehealth company.